Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giuliano

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
ESMO Open|August 9, 2024
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialF Poggio, E Blondeaux, M Tagliamento, et al.
ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.
ESMO Open|January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsA Gravina, P Gargiulo, M De Laurentiis, et al.
ESMO Open|July 7, 2026
Real-world evidence of sacituzumab govitecan in metastatic triple-negative breast cancer: an updated multicenter analysisR Caputo, G Buono, C Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 studyL Provenzano, M V Dieci, G Curigliano, et al.
Astronomy and Astrophysics|June 4, 2019
Gas phase Elemental abundances in Molecular cloudS (GEMS): I. The prototypical dark cloud TMC 1A Fuente, D G Navarro, P Caselli, et al.
Astronomy and Astrophysics|June 23, 2020
Gas phase Elemental abundances in Molecular cloudS (GEMS) II. On the quest for the sulphur reservoir in molecular clouds: the H<sub>2</sub>S caseD Navarro-Almaida, R Le Gal, A Fuente, et al.
Tumori|March 19, 2017
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologistsCarlo Furlan, Stefano Arcangeli, Michele Avanzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)C Proto, M Ganzinelli, S Manglaviti, et al.
Allergy|August 29, 2023
UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action planJean Bousquet, Boleslaw Samolinski, Igor Kaidashev, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
ESMO Open|August 9, 2024
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialF Poggio, E Blondeaux, M Tagliamento, et al.
ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.
ESMO Open|January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsA Gravina, P Gargiulo, M De Laurentiis, et al.
ESMO Open|July 7, 2026
Real-world evidence of sacituzumab govitecan in metastatic triple-negative breast cancer: an updated multicenter analysisR Caputo, G Buono, C Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 studyL Provenzano, M V Dieci, G Curigliano, et al.
Astronomy and Astrophysics|June 4, 2019
Gas phase Elemental abundances in Molecular cloudS (GEMS): I. The prototypical dark cloud TMC 1A Fuente, D G Navarro, P Caselli, et al.
Astronomy and Astrophysics|June 23, 2020
Gas phase Elemental abundances in Molecular cloudS (GEMS) II. On the quest for the sulphur reservoir in molecular clouds: the H<sub>2</sub>S caseD Navarro-Almaida, R Le Gal, A Fuente, et al.
Tumori|March 19, 2017
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologistsCarlo Furlan, Stefano Arcangeli, Michele Avanzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)C Proto, M Ganzinelli, S Manglaviti, et al.
Allergy|August 29, 2023
UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action planJean Bousquet, Boleslaw Samolinski, Igor Kaidashev, et al.
Pageof 18